Wong F - Search Results

1

Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump.

Wong F, Bendel E, Sniderman K, Frederick T, Haskal ZJ, Sanyal A, Asrani SK, Capel J, Kamath PS. Wong F, et al. Liver Transpl. 2020 May;26(5):651-661. doi: 10.1002/lt.25724. Epub 2020 Mar 22. Liver Transpl. 2020. PMID: 31999044 Free PMC article.

2

The North American Study for the Treatment of Refractory Ascites.

Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T; North American Study for the Treatment of Refractory Ascites Group. Sanyal AJ, et al. Among authors: wong f. Gastroenterology. 2003 Mar;124(3):634-41. doi: 10.1053/gast.2003.50088. Gastroenterology. 2003. PMID: 12612902 Clinical Trial.

3

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.

Wong F, Pantea L, Sniderman K. Wong F, et al. Hepatology. 2004 Jul;40(1):55-64. doi: 10.1002/hep.20262. Hepatology. 2004. PMID: 15239086 Clinical Trial.

4

Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy.

Campbell MS, Brensinger CM, Sanyal AJ, Gennings C, Wong F, Kowdley KV, McCashland T, Reddy KR. Campbell MS, et al. Among authors: wong f. Hepatology. 2005 Sep;42(3):635-40. doi: 10.1002/hep.20840. Hepatology. 2005. PMID: 16108073 Clinical Trial.

5

The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.

Therapondos G, Hol L, Benjaminov F, Wong F. Therapondos G, et al. Among authors: wong f. Hepatology. 2006 Sep;44(3):640-9. doi: 10.1002/hep.21309. Hepatology. 2006. PMID: 16941706

6

The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.

Rabie RN, Cazzaniga M, Salerno F, Wong F. Rabie RN, et al. Among authors: wong f. Am J Gastroenterol. 2009 Oct;104(10):2458-66. doi: 10.1038/ajg.2009.321. Epub 2009 Jun 16. Am J Gastroenterol. 2009. PMID: 19532126

7

Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.

Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS. Salerno F, et al. Among authors: wong f. Liver Int. 2010 Aug;30(7):937-47. doi: 10.1111/j.1478-3231.2010.02272.x. Epub 2010 May 21. Liver Int. 2010. PMID: 20492521 Review.

8

Medical management of ascites.

Leung W, Wong F. Leung W, et al. Among authors: wong f. Expert Opin Pharmacother. 2011 Jun;12(8):1269-83. doi: 10.1517/14656566.2011.549126. Epub 2011 Feb 10. Expert Opin Pharmacother. 2011. PMID: 21306283 Review.

9

Management of ascites in cirrhosis.

Wong F. Wong F. J Gastroenterol Hepatol. 2012 Jan;27(1):11-20. doi: 10.1111/j.1440-1746.2011.06925.x. J Gastroenterol Hepatol. 2012. PMID: 21916992 Review.

10

Bacterial infections in end-stage liver disease: current challenges and future directions.

Bajaj JS, O'Leary JG, Wong F, Reddy KR, Kamath PS. Bajaj JS, et al. Among authors: wong f. Gut. 2012 Aug;61(8):1219-25. doi: 10.1136/gutjnl-2012-302339. Epub 2012 Jun 3. Gut. 2012. PMID: 22661495 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,546 results

Search Page

Filters